Pakistan State Oil (PSO) has appointed Abdus Sami as interim CEO effective March 31, 2026. He brings over 24 years of ...
Takeda Pharmaceutical (NYSE:TAK) highlighted late-breaking Phase III data for investigational TYK2 inhibitor zasocitinib in ...
Titilagarh BJP MLA Nabin Kumar Jain has stirred a huge controversy for engaging in celebratory fire during a Ram Navami procession in the ...
Envudeucitinib, another allosteric TYK2 inhibitor, also achieved PASI 75 in 70-75% of patients at 16 weeks and PGA 0/1 status ...
Lilly's Ebglyss delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis: Indianapolis Monday, March 30, 2026, 12:00 Hrs [IST] ...
EBGLYSS (lebrikizumab-lbkz) delivered durable skin clearance and relief from persistent itch for up to four years for ...
Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints: Indianapolis Tuesday, ...
Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including ...
PSO says there have been six power outages between November and December. The electric company says power outages have lasted from a few minutes to just under five hours. “We understand that it’s not ...
The industrial landscape has undergone a massive shift in just a handful of years. Costs have skyrocketed, the labor market is quickly thinning, and AI has rapidly impacted every role. All of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results